Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214)

R Timothy D Oliver, Graham M Mead, Gordon J S Rustin, Johnathan K Joffe, Nina Aass, Robert Coleman, Rhian Gabe, Philip Pollock, Sally P Stenning

Research output: Contribution to journalArticlepeer-review

Abstract

Initial results of a randomized trial comparing carboplatin with radiotherapy (RT) as adjuvant treatment for stage I seminoma found carboplatin had a noninferior relapse-free rate (RFR) and had reduced contralateral germ cell tumors (GCTs) in the short-term. Updated results with a median follow-up of 6.5 years are now reported.
Original languageEnglish
Pages (from-to)957-962
Number of pages6
JournalJournal of Clinical Oncology
Volume29
Issue number8
DOIs
Publication statusPublished - 10 Mar 2011

Cite this